Sasaki M - Search Results

1

Single nucleotide polymorphisms of estrogen receptor alpha in human renal cell carcinoma.

Tanaka Y, Sasaki M, Kaneuchi M, Fujimoto S, Dahiya R. Tanaka Y, et al. Among authors: sasaki m. Biochem Biophys Res Commun. 2002 Sep 6;296(5):1200-6. doi: 10.1016/s0006-291x(02)02045-4. Biochem Biophys Res Commun. 2002. PMID: 12207901

2

Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer.

Sasaki M, Tanaka Y, Perinchery G, Dharia A, Kotcherguina I, Fujimoto Si, Dahiya R. Sasaki M, et al. J Natl Cancer Inst. 2002 Mar 6;94(5):384-90. doi: 10.1093/jnci/94.5.384. J Natl Cancer Inst. 2002. PMID: 11880477

3

Polymorphisms of the CYP1B1 gene have higher risk for prostate cancer.

Tanaka Y, Sasaki M, Kaneuchi M, Shiina H, Igawa M, Dahiya R. Tanaka Y, et al. Among authors: sasaki m. Biochem Biophys Res Commun. 2002 Aug 30;296(4):820-6. doi: 10.1016/s0006-291x(02)02004-1. Biochem Biophys Res Commun. 2002. PMID: 12200121

4

Polymorphisms of estrogen receptor alpha gene in endometrial cancer.

Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R. Sasaki M, et al. Biochem Biophys Res Commun. 2002 Sep 27;297(3):558-64. doi: 10.1016/s0006-291x(02)02248-9. Biochem Biophys Res Commun. 2002. PMID: 12270131

5

The CAG repeats in exon 1 of the androgen receptor gene are significantly longer in endometrial cancer patients.

Sasaki M, Sakuragi N, Dahiya R. Sasaki M, et al. Biochem Biophys Res Commun. 2003 Jun 13;305(4):1105-8. doi: 10.1016/s0006-291x(03)00883-0. Biochem Biophys Res Commun. 2003. PMID: 12767946

6

Estrogen receptor alpha polymorphisms and renal cell carcinoma--a possible risk.

Tanaka Y, Sasaki M, Kaneuchi M, Fujimoto S, Dahiya R. Tanaka Y, et al. Among authors: sasaki m. Mol Cell Endocrinol. 2003 Apr 28;202(1-2):109-16. doi: 10.1016/s0303-7207(03)00071-6. Mol Cell Endocrinol. 2003. PMID: 12770739 Review.

7

CYP1B1 gene in endometrial cancer.

Sasaki M, Kaneuchi M, Fujimoto S, Tanaka Y, Dahiya R. Sasaki M, et al. Mol Cell Endocrinol. 2003 Apr 28;202(1-2):171-6. doi: 10.1016/s0303-7207(03)00079-0. Mol Cell Endocrinol. 2003. PMID: 12770747 Review.

8

Hypermethylation can selectively silence multiple promoters of steroid receptors in cancers.

Sasaki M, Kaneuchi M, Fujimoto S, Tanaka Y, Dahiya R. Sasaki M, et al. Mol Cell Endocrinol. 2003 Apr 28;202(1-2):201-7. doi: 10.1016/s0303-7207(03)00084-4. Mol Cell Endocrinol. 2003. PMID: 12770752

9

Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.

Sasaki M, Kaneuchi M, Sakuragi N, Dahiya R. Sasaki M, et al. Cancer Res. 2003 Jun 15;63(12):3101-6. Cancer Res. 2003. PMID: 12810635

10

CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions.

Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R. Sasaki M, et al. Cancer Res. 2003 Jul 15;63(14):3913-8. Cancer Res. 2003. Retraction in: Cancer Res. 2017 Sep 15;77(18):5211. doi: 10.1158/0008-5472.CAN-17-2475 PMID: 12873984 Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,086 results

Search Page

Filters